In that sense, the bovine dialyzable leukocyte extract (bDLE), IMMUNEPOTENT CRP (ICRP), is an immunotherapy with cytotoxic potential in several cancer cell lines (Franco-Molina et al., 2006[10]) including breast cancer cells, without affecting non-cancerous cells (Martínez-Torres et al., 2020[22]; Lorenzo-Anota et al., 2020[19]). The gene discussed is CRP; the disease is cancer.